NDNathan Davies

Nathan Davies

*This is an algorithmically generated author record based on publicly available information.

Nathan Davies has a total of 5 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Small numbers of clusters in cluster randomised trials: a scoping review of problems and proposed solutions

    by Olivier Quintin, Jessica Kasza, Nathan Davies, Sarah Markham, Richard Hooper

  • Open Access

    Small numbers of clusters in cluster randomised trials: a scoping review of problems and proposed solutions

    by Olivier Quintin, J Kasza, Nathan Davies, Sarah Markham, Richard Hooper

    ObjectivesCluster randomised trials (CRTs) are commonly used to evaluate healthcare interventions and policies in “real-world” settings. Many CRTs include only a limited number of clusters for practical, logistical, or methodological reasons. Small numbers of clusters are associated with known analytical and design challenges, though there is little consensus on exactly what constitutes a “small” number in practice. Identifying problems and potential solutions will help researchers plan more effective evaluations.MethodsWe performed a scoping review of the literature to identify any problems and/or potential solutions related to small numbers of clusters for any type of CRT. We identified 53 references from the Ovid, MedLine and Embase databases.ResultsMost articles focus specifically either on parallel group CRTs or on stepped wedge CRTs (17 (32.1%) sources each). Challenges related to Type I error rate inflation or other inferential issues are identified in 32 (60.4%) sources, and the risk of covariate imbalance between trial arms in 30 (56.6%), making these the most commonly mentioned problems. A variety of methods to control Type I error rate inflation have been proposed, but with some concerns raised over their performance down to very small numbers of clusters. Operational definitions of a “small” number of clusters vary considerably across the literature from 3 to 50 (median 20). Most published stepped wedge trials, in particular, are what most methodological articles would call small (in terms of number of clusters).ConclusionsWork on mitigating the problems arising from small numbers of clusters has tended to focus on the analysis of CRTs rather than their design (e.g. sample size justification) or conduct. Further work is still needed to develop simple, practical guidance to help triallists understand what challenges they will face and when, and how to optimise the performance of methods for CRTs with limited numbers of clusters.